Regenxbio (RGNX) Other Non-Current Assets (2015 - 2025)

Regenxbio's Other Non-Current Assets history runs 11 years deep, the most recent figure standing at $2.0 million for Q4 2025.

• On a quarterly basis, Other Non-Current Assets changed 0.0% year-over-year to $2.0 million in Q4 2025; TTM through Dec 2025 was $2.0 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $2.0 million, changed 0.0% from the prior year.
• Other Non-Current Assets was little changed at $2.0 million in Q4 2025 per RGNX's latest filing, from $2.0 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $3.0 million in Q1 2025 and bottomed at $1.3 million in Q1 2021.
• The 5-year median for Other Non-Current Assets is $2.0 million (2021), against an average of $2.0 million.
• Across the five-year window, Other Non-Current Assets jumped 52.63% in 2021 and dropped 9.98% in 2024, its largest moves.
• Year by year, Other Non-Current Assets stood at $2.0 million in 2021, then changed by 0.0% to $2.0 million in 2022, then changed by 0.0% to $2.0 million in 2023, then changed by 0.0% to $2.0 million in 2024, then changed by 0.0% to $2.0 million in 2025.
• Per Business Quant, the three latest RGNX Other Non-Current Assets figures stand at $2.0 million (Q4 2025), $2.0 million (Q3 2025), and $2.0 million (Q2 2025).